SCHEMBL7155287

SCHEMBL7155287

[CH2]c1nccn1CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3158473 0.76
SCHEMBL8026054 0.71
SCHEMBL6647390 0.71
SCHEMBL28209761 0.71
Methyl Alcohol SCHEMBL28217540 0.70 KMT2A (0.53)
SCHEMBL11618141 0.68
SCHEMBL17292432 0.67
SCHEMBL9810706 0.67 SMN1; SMN2 (0.57)
SCHEMBL27268233 0.67
SCHEMBL20744563 0.66 SMN1; SMN2 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6645960-B1 Antiprotozoa agents for animal or human infections GLAXO WELLCOME S.A. (ES) 2003-11-11 US disclosed
US-6436930-B1 FOR TREATMENT OF INFECTIONS BY CANDIDA ALBICANS BRISTOL-MYERS SQUIBB COMPANY 2002-08-20 US disclosed
EP-1228049-A1 ANTIFUNGAL SORDARICIN DERIVATIVES Glaxo Wellcome S.A. (ES) 2002-08-07 EP disclosed
US-20020035073-A1 Novel thio derivatives of sordarin as antifungal agents BRISTOL-MYERS SQUIBB COMPANY 2002-03-21 US disclosed
WO-2001034583-A1 ANTIFUNGAL SORDARICIN DERIVATIVES GLAXO WELLCOME SA (ES) 2001-05-17 WO disclosed
EP-1077959-A1 MORPHOLINO ETHERS Glaxo Wellcome S.A. (ES) 2001-02-28 EP disclosed
WO-1999058512-A1 MORPHOLINO ETHERS GLAXO WELLCOME S.A. (ES) 1999-11-18 WO disclosed